论文部分内容阅读
本文收集１９９２年１月至１９９５年５月在我科作肝动脉化疗栓塞术（ＴＡＥ）和肝动脉化疗灌注术（ＴＡＩ）的中晚期肝癌１６０例，将每例病人的肝动脉造影所见与临床资料及随访结果一起进行分析。结果发现１６０例中，有肝动脉变异者２５例，占全部病例的１５．６％，表明肝动脉变异发生率较高。同时发现有些病例虽然肝动脉及其分支无变异，但肝动脉走行位置变异，对选择性肝动脉插管有较大影响。作者对肝动脉变异的类型、肝动脉走行位置异常、以及它们在肝癌介入治疗中的意义进行了讨论。
This article collected 160 cases of advanced hepatocellular carcinoma (TAE) and hepatic arterial chemoembolization (TAI) in our department from January 1992 to May 1995, and observed the hepatic arteriography of each patient. Clinical data and follow-up results were analyzed together. The results showed that in 160 cases, there were 25 cases of hepatic artery variability, accounting for 15.6% of all cases, indicating a higher incidence of hepatic artery variability. At the same time, it was found that in some cases, although there was no variation in the hepatic artery and its branches, the location of the hepatic artery ran into variations, which had a great influence on the selective hepatic artery catheterization. The authors discuss the types of hepatic arterial variation, abnormalities of hepatic arterial walking locations, and their significance in interventional treatment of liver cancer.